U3 Pharma Ag's Series B Round

U3 Pharma Ag raised a round of funding on September 15, 2003.

U3 Pharma AG is involved in targeted cancer drug development. The Company is advancing a portfolio of novel antibody-based therapeutics that will be used as mono therapies and combination therapies fo…

Articles about U3 Pharma Ag's Series B Round: